{"id":"https://openalex.org/W2010387580","doi":"https://doi.org/10.1097/00002030-200405210-00007","title":"Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide","display_name":"Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide","publication_year":2004,"publication_date":"2004-05-01","ids":{"openalex":"https://openalex.org/W2010387580","doi":"https://doi.org/10.1097/00002030-200405210-00007","mag":"2010387580","pmid":"https://pubmed.ncbi.nlm.nih.gov/15166529"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200405210-00007","doi":"https://doi.org/10.1097/00002030-200405210-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200405210-00007","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028130303","display_name":"Bonaventura Clotet","orcid":"https://orcid.org/0000-0003-3232-4598","observed_orcids":["https://orcid.org/0000-0003-3232-4598"]},"institutions":[{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Bonaventura Clotet","raw_affiliation_strings":["Hospital Universitari Germans Trias i Pujol and the Institut de Recerca de la SIDA-Caixa Foundation, Badalona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari Germans Trias i Pujol and the Institut de Recerca de la SIDA-Caixa Foundation, Badalona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110529468","display_name":"Fran\u00e7ois Raffi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Raffi","raw_affiliation_strings":["Centre Hospitalier Universitaire H\u00f4tel Dieu, Nantes, France","Hotel Dieu CHU de Nantes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire H\u00f4tel Dieu, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"Hotel Dieu CHU de Nantes","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107834622","display_name":"David A. Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David Cooper","raw_affiliation_strings":["National Centre in","University Of New south Wales"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in","institution_ids":[]},{"raw_affiliation_string":"University Of New south Wales","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110111187","display_name":"Jean\u2010Fran\u00e7ois Delfraissy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210162942","display_name":"Bic\u00eatre Hospital","ror":"https://ror.org/05c9p1x46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210162942","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Fran\u00e7ois Delfraissy","raw_affiliation_strings":["Centre Hospitalier Universitaire Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Paris, France","Universite Paris Sud"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210162942"]},{"raw_affiliation_string":"Universite Paris Sud","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021984756","display_name":"Adriano Lazzarin","orcid":"https://orcid.org/0000-0003-2551-7754","observed_orcids":["https://orcid.org/0000-0003-2551-7754"]},"institutions":[{"id":"https://openalex.org/I154387261","display_name":"Vita-Salute San Raffaele University","ror":"https://ror.org/01gmqr298","country_code":"IT","type":"education","lineage":["https://openalex.org/I154387261"]},{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4387155925","display_name":"IRCCS San Raffaele Roma","ror":"https://ror.org/006x48140","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387155925"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Adriano Lazzarin","raw_affiliation_strings":["Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Vita-Salute University, Milan, Italy","IRCCS Ospedale San Raffaele"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Vita-Salute University, Milan, Italy","institution_ids":["https://openalex.org/I154387261","https://openalex.org/I4387155925"]},{"raw_affiliation_string":"IRCCS Ospedale San Raffaele","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054671965","display_name":"Graeme J Moyle","orcid":"https://orcid.org/0000-0002-2395-3774","observed_orcids":["https://orcid.org/0000-0002-2395-3774"]},"institutions":[{"id":"https://openalex.org/I4210136304","display_name":"Chelsea and Westminster Hospital","ror":"https://ror.org/038zxea36","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graeme Moyle","raw_affiliation_strings":["Chelsea and Westminster Hospital, London, UK, the","Imperial College London,#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chelsea and Westminster Hospital, London, UK, the","institution_ids":["https://openalex.org/I4210136304"]},{"raw_affiliation_string":"Imperial College London,#TAB#","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054617732","display_name":"J\u00fcrgen Kurt Rockstroh","orcid":"https://orcid.org/0000-0003-2858-3888","observed_orcids":["https://orcid.org/0000-0003-2858-3888"]},"institutions":[{"id":"https://openalex.org/I135140700","display_name":"University of Bonn","ror":"https://ror.org/041nas322","country_code":"DE","type":"education","lineage":["https://openalex.org/I135140700"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J\u00fcrgen Rockstroh","raw_affiliation_strings":["Department of Medicine I, University of Bonn, Bonn, Germany, the","University of Bonn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine I, University of Bonn, Bonn, Germany, the","institution_ids":["https://openalex.org/I135140700"]},{"raw_affiliation_string":"University of Bonn","institution_ids":["https://openalex.org/I135140700"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009751300","display_name":"Vincent Soriano","orcid":"https://orcid.org/0000-0002-4624-5199","observed_orcids":["https://orcid.org/0000-0002-4624-5199"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4387152292","display_name":"Carlos III Hospital","ror":"https://ror.org/05ntpq911","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746","https://openalex.org/I4387152292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vincent Soriano","raw_affiliation_strings":["Infectious Diseases Unit, Hospital Carlos III, Madrid, Spain, and","Hospital Carlos III"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Unit, Hospital Carlos III, Madrid, Spain, and","institution_ids":["https://openalex.org/I4387152292"]},{"raw_affiliation_string":"Hospital Carlos III","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4387152292"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110224117","display_name":"Jonathan Schapiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Jonathan Schapiro","raw_affiliation_strings":["Sheba Medical Center, Tel Aviv, Israel","Sheba Medical Center At Tel Hashomer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheba Medical Center, Tel Aviv, Israel","institution_ids":["https://openalex.org/I2799810450"]},{"raw_affiliation_string":"Sheba Medical Center At Tel Hashomer","institution_ids":["https://openalex.org/I2799810450"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":15,"corresponding_author_ids":["https://openalex.org/A5028130303"],"corresponding_institution_ids":["https://openalex.org/I4210153460"],"apc_list":null,"apc_paid":null,"fwci":9.1009,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.98174131,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"18","issue":"8","first_page":"1137","last_page":"1146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enfuvirtide","display_name":"enfuvirtide","score":1.0},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9559999704360962},{"id":"https://openalex.org/keywords/treatment-experienced-patients","display_name":"treatment-experienced patients","score":0.9929999709129333},{"id":"https://openalex.org/keywords/fusion-inhibitors","display_name":"fusion inhibitors","score":0.6740000247955322},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8360000252723694},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.722000002861023},{"id":"https://openalex.org/keywords/antiretroviral-resistance-testing","display_name":"antiretroviral resistance testing","score":0.859000027179718},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.7120000123977661},{"id":"https://openalex.org/keywords/bacterial-pneumonia","display_name":"bacterial pneumonia","score":0.7250000238418579},{"id":"https://openalex.org/keywords/patient-adherence","display_name":"patient adherence","score":0.5239999890327454},{"id":"https://openalex.org/keywords/patient-support","display_name":"patient support","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C2778037500","wikidata":"https://www.wikidata.org/wiki/Q423327","display_name":"Enfuvirtide","level":5,"score":0.9979904890060425},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6851447820663452},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6408355832099915},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5361758470535278},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4731230139732361},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.4477246403694153},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39766931533813477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3873331546783447},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3397185206413269},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.24549797177314758},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18845462799072266},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.0845104455947876},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077560","descriptor_name":"Enfuvirtide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007271","descriptor_name":"Injections, Intradermal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010353","descriptor_name":"Patient Education as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002030-200405210-00007","doi":"https://doi.org/10.1097/00002030-200405210-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200405210-00007","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:15166529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15166529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Consensus Statement"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W191242174","https://openalex.org/W1537640815","https://openalex.org/W1991859498","https://openalex.org/W1997486490","https://openalex.org/W2016718862","https://openalex.org/W2023270608","https://openalex.org/W2033757712","https://openalex.org/W2036656105","https://openalex.org/W2040506631","https://openalex.org/W2048336729","https://openalex.org/W2113972880","https://openalex.org/W2133649749","https://openalex.org/W2146478787","https://openalex.org/W2153747683","https://openalex.org/W2154040655","https://openalex.org/W2172463082","https://openalex.org/W2321460134","https://openalex.org/W2325577815","https://openalex.org/W4300892676"],"related_works":["https://openalex.org/W1959324364","https://openalex.org/W2096054385","https://openalex.org/W1856506545","https://openalex.org/W7100791310","https://openalex.org/W2160633544","https://openalex.org/W2408973832","https://openalex.org/W2112082353","https://openalex.org/W2046398278","https://openalex.org/W7119377255","https://openalex.org/W2398070823"],"abstract_inverted_index":{"The":[0],"introduction":[1],"of":[2,12,28,59,98,152,162,226,236,252],"enfuvirtide":[3,33,141,175,197],"(FUZEON)":[4],"represents":[5],"an":[6,137,154,234],"important":[7],"advance":[8],"in":[9,47,53,107,257,268],"the":[10,22,79,117,150,160,250],"treatment":[11,147],"therapy-experienced":[13],"patients":[14,29,61],"with":[15,109,149,229],"HIV-1":[16],"infection.":[17],"However,":[18,72],"parenteral":[19],"self-administration,":[20],"and":[21,25,51,89,146,198,207,214,239,248,271],"advanced":[23],"disease":[24],"antiretroviral":[26,105],"experience":[27],"currently":[30],"most":[31],"needing":[32],"introduce":[34],"unique":[35],"usage":[36],"considerations.":[37],"Enfuvirtide":[38],"has":[39],"been":[40,220],"shown":[41],"to":[42,115,128,264],"provide":[43],"clinically":[44],"relevant":[45],"improvements":[46],"CD4":[48,80],"cell":[49,81],"counts":[50],"reductions":[52],"HIV":[54],"viraemia":[55,90],"across":[56],"all":[57,202],"subgroups":[58],"treatment-experienced":[60],"studied,":[62],"including":[63],"those":[64],"taking":[65],"few":[66],"or":[67,103,111,156,185,210],"no":[68,171],"other":[69,113],"active":[70],"drugs.":[71],"optimal":[73],"outcome":[74],"results":[75],"from":[76],"initiation":[77],"when":[78],"count":[82],"is":[83,170,188],"above":[84],"100":[85],"x":[86,93],"10(6)":[87],"cells/l":[88],"below":[91],"1":[92],"10(5)":[94],"copies/ml,":[95],"as":[96],"part":[97],"a":[99,163,230],"newly":[100],"constructed":[101],"third":[102],"fourth":[104],"regimen":[106],"combination":[108],"one":[110],"two":[112],"antiretrovirals":[114],"which":[116],"virus":[118],"remains":[119],"sensitive.":[120],"Resistance":[121],"testing":[122],"should":[123,142,176],"be":[124,144,177,262],"used":[125],"where":[126,168],"available":[127],"guide":[129],"background":[130,139],"drug":[131],"selection.":[132],"Where":[133],"insufficient":[134],"options":[135],"for":[136],"effective":[138],"exist,":[140],"still":[143],"considered":[145],"undertaken":[148],"aim":[151],"achieving":[153],"immunological":[155,184],"clinical":[157,186],"response,":[158],"despite":[159],"unlikelihood":[161],"sustained":[164],"virological":[165,180],"outcome.":[166],"Similarly,":[167],"there":[169],"viable":[172],"alternative":[173],"treatment,":[174],"continued":[178],"following":[179],"failure":[181],"wherever":[182],"ongoing":[183,237],"benefit":[187,272],"discerned.":[189],"Injection":[190],"site":[191],"reactions":[192,217],"(ISRs)":[193],"are":[194,205],"common":[195],"on":[196,273],"will":[199],"affect":[200],"almost":[201],"patients.":[203],"ISRs":[204],"manageable":[206],"seldom":[208],"activity-":[209],"treatment-limiting.":[211],"Bacterial":[212],"pneumonia":[213],"systemic":[215],"hypersensitivity":[216],"have":[218],"also":[219],"reported":[221],"uncommonly.":[222],"A":[223],"structured":[224],"series":[225],"patient":[227,269],"visits":[228],"healthcare":[231],"professional":[232],"provides":[233],"atmosphere":[235],"training":[238],"support":[240],"that":[241],"may":[242],"prevent":[243],"'injection":[244],"fatigue',":[245],"maintain":[246],"adherence":[247],"minimise":[249],"incidence":[251],"ISRs.":[253],"An":[254],"initial":[255],"investment":[256],"establishing":[258],"such":[259],"procedures":[260],"can":[261],"expected":[263],"yield":[265],"significant":[266],"returns":[267],"confidence":[270],"enfuvirtide.":[274]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}